{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["13(11)"],"submitter":["Felek D"],"pubmed_abstract":["This study investigates the potential role of microplastics in the development of diabetes mellitus and assesses their presence in individuals undergoing insulin therapy. A total of 100 participants were included: 50 insulin-dependent diabetic patients and 50 healthy controls. The diabetic group was divided into two subgroups based on their insulin regimen: those receiving one daily injection of basal insulin and those receiving four injections of basal and short-acting insulin. Blood samples were analysed for microplastic content using chromatographic methods (LC/GC-MSMS and LCTOF MS). The findings revealed that diabetic patients had significantly higher serum microplastic levels (3.14 ± 1.30 µg/mL) than healthy individuals (1.50 ± 0.89 µg/mL, <i>p</i> < 0.05). Within the diabetic group, "],"journal":["Toxics"],"pagination":["926"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12656115"],"repository":["biostudies-literature"],"pubmed_title":["Assessment of Microplastic Exposure in Diabetic Patients Using Insulin."],"pmcid":["PMC12656115"],"pubmed_authors":["Erkoc MF","Yaylacı M","Felek D","Turksoy VA"],"additional_accession":[]},"is_claimable":false,"name":"Assessment of Microplastic Exposure in Diabetic Patients Using Insulin.","description":"This study investigates the potential role of microplastics in the development of diabetes mellitus and assesses their presence in individuals undergoing insulin therapy. A total of 100 participants were included: 50 insulin-dependent diabetic patients and 50 healthy controls. The diabetic group was divided into two subgroups based on their insulin regimen: those receiving one daily injection of basal insulin and those receiving four injections of basal and short-acting insulin. Blood samples were analysed for microplastic content using chromatographic methods (LC/GC-MSMS and LCTOF MS). The findings revealed that diabetic patients had significantly higher serum microplastic levels (3.14 ± 1.30 µg/mL) than healthy individuals (1.50 ± 0.89 µg/mL, <i>p</i> < 0.05). Within the diabetic group, ","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Oct","modification":"2026-05-20T03:18:38.146Z","creation":"2026-05-20T03:09:01.695Z"},"accession":"S-EPMC12656115","cross_references":{"pubmed":["41304478"],"doi":["10.3390/toxics13110926"]}}